Jon Chen — SPARQNOW

At-a-Glance

Co-founder & CEO at Infiltrate Bio
Technology Co-founder of IsoPlexis, which completed an IPO in 2021
Participated in Startup Fellowship 002 at Palantir Technologies
Served as VP of Brand & Corporate Marketing at Bruker Cellular Analysis (formerly PhenomeX)

Biography

Jon Chen is a co-founder and CEO with a background in biotechnology and corporate marketing. He currently leads Infiltrate Bio as its Co-founder and CEO.

Previously, Chen was the Technology Co-founder at IsoPlexis, a company that successfully completed an IPO in 2021. His career also includes a Startup Fellowship 002 at Palantir Technologies and a role as VP of Brand & Corporate Marketing at Bruker Cellular Analysis, formerly known as PhenomeX.